Recent Patents on Anti-Infective Drug Discovery
Volume 15, 3 Issues, 2020
ISSN: 2212-4071 (Online)
ISSN: 1574-891X (Print)
This journal supports open access
ISSN: 2212-4071 (Online)
ISSN: 1574-891X (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Recent Patents on Anti-Infective Drug Discovery, Volume 1 - Number 1
Patented HIV-1 Integrase Inhibitors (1998-2005)
, 1(1): 1 - 15Philippe Cotelle
DOI: 10.2174/157489106775244082
Recent Progress in Pharmacological Research of Antioxidants in Pathological Conditions: Cardiovascular Health
, 1(1): 17 - 31Victor M. Victor, Kenneth J. McCreath and Milagros Rocha
DOI: 10.2174/157489106775244136
Promising Drugs Against Tuberculosis
, 1(1): 33 - 44Marcus V. N. de Souza
DOI: 10.2174/157489106775244163
Recent Advances in Flavivirus Antiviral Drug Discovery and Vaccine Development
, 1(1): 45 - 55Debashish Ray and Pei-Yong Shi
DOI: 10.2174/157489106775244055
C5a, a Therapeutic Target in Sepsis
, 1(1): 57 - 65Ren-Feng Guo and Peter A. Ward
DOI: 10.2174/157489106775244091
An Insight on the Leading HIV Entry Inhibitors
, 1(1): 67 - 73Ana S. Veiga, Nuno C. Santos and Miguel A. R. B. Castanho
DOI: 10.2174/157489106775244046
Current Status and Future of Antifungal Therapy for Systemic Mycoses
, 1(1): 75 - 84Joshua D. Nosanchuk
DOI: 10.2174/157489106775244109
Pegylated Interferons for the Treatment of Chronic Hepatitis B
, 1(1): 85 - 94Chun-Jen Liu and Jia-Horng Kao
DOI: 10.2174/157489106775244154
Attack on the Scourge of Tuberculosis: Patented Drug Targets
, 1(1): 95 - 106Reena Vohra, Meetu Gupta, Rekha Chaturvedi and Yogendra Singh
DOI: 10.2174/157489106775244127
Inhibition of HIV-1 Entry into Cells
, 1(1): 107 - 112Karen F.T. Copeland
DOI: 10.2174/157489106775244118
Editor-in-Chief
Tianhong Dai
Massachusetts General Hospital
Harvard Medical School
Boston, MA
(USA)
Biography
Massachusetts General Hospital
Harvard Medical School
Boston, MA
Biography
Biography of Tianhong Dai
Tianhong Dai is an assistant professor with the Harvard Medical School. He is considered a world leader in antimicrobial blue light therapy for infections, and a world expert in animal models of wound infections using bioluminescent microbes. He is the author and co-author of more than 80 peer-reviewed publications. Dr. Dai’s research has been supported by the NIH (R01 and R21), DoD and other funding sources.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Recent Patents on Anti-Infective Drug Discovery was launched in 2006. Dr. Tianhong Dai serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.10
New eBook
 |
Frontiers in Clinical Drug Research-Anti InfectivesYou can view the contents of this eBook [here] or purchase it [here]. |
Advertisement
Webmaster Contact: info@benthamscience.net